Michael Lee

Array ( [id] => 14196437 [patent_doc_number] => 10265304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => Nootropic compositions for improving memory performance [patent_app_type] => utility [patent_app_number] => 15/783380 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15691 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12259341 [patent_doc_number] => 20180078537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'SYSTEMIC TREATMENT OF BLOOD-SUCKING AND BLOOD-CONSUMING PARASITES BY ORAL ADMINISTRATION OF A PARASITICIDAL AGENT' [patent_app_type] => utility [patent_app_number] => 15/730565 [patent_app_country] => US [patent_app_date] => 2017-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8494 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12157265 [patent_doc_number] => 20180028530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'Role of N-2-Hydroxy-Ethyl-Piperazine-N\'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury' [patent_app_type] => utility [patent_app_number] => 15/725007 [patent_app_country] => US [patent_app_date] => 2017-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13325727 [patent_doc_number] => 20180214401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => METHOD FOR TREATING SCARS WITH ADAPALENE 0.3% [patent_app_type] => utility [patent_app_number] => 15/723551 [patent_app_country] => US [patent_app_date] => 2017-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5615 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15723551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14712525 [patent_doc_number] => 20190247326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => IDENTIFICATION OF SEIZURE SUSCEPTIBILITY REGION IN WOLF-HIRSCHHORN SYNDROME AND TREATMENT THEREOF [patent_app_type] => utility [patent_app_number] => 16/335234 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25070 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12157286 [patent_doc_number] => 20180028551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics' [patent_app_type] => utility [patent_app_number] => 15/707194 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7227 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12117226 [patent_doc_number] => 20180000812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'TREATMENT OF CROHN\'S DISEASE WITH LAQUINIMOD' [patent_app_type] => utility [patent_app_number] => 15/703496 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8041 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14621637 [patent_doc_number] => 20190224186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => TREATMENT OF MULTIPLE SCLEROSIS WITH CHS-131 [patent_app_type] => utility [patent_app_number] => 16/333171 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12637299 [patent_doc_number] => 20180104263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => BUTYRYLCHOLINESTERASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/699944 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13714123 [patent_doc_number] => 20170368016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => METHOD FOR REVERSING, PREVENTING, DELAYING OR STABILIZING SOFT TISSUE CALCIFICATION [patent_app_type] => utility [patent_app_number] => 15/694876 [patent_app_country] => US [patent_app_date] => 2017-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18165355 [patent_doc_number] => 20230031954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT [patent_app_type] => utility [patent_app_number] => 16/328559 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13687385 [patent_doc_number] => 20170354647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator [patent_app_type] => utility [patent_app_number] => 15/687824 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12975625 [patent_doc_number] => 20170340625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 15/679495 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14813 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12880630 [patent_doc_number] => 20180185385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS [patent_app_type] => utility [patent_app_number] => 15/677665 [patent_app_country] => US [patent_app_date] => 2017-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12049814 [patent_doc_number] => 20170326158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'Spironolactone Aqueous Compositions' [patent_app_type] => utility [patent_app_number] => 15/665014 [patent_app_country] => US [patent_app_date] => 2017-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15674 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15665014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029478 [patent_doc_number] => 20170319577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'COMBINATIONS OF OPIOID/TLR4 ANTAGONIST AND ACETYL-PARA-AMINOPHENOL (APAP) FOR USE IN THE REDUCTION OF TOLL-LIKE RECEPTOR 4(TLR4) AND CYCLOOXYGENASE-2 (COX-2) ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/651926 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4104 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022159 [patent_doc_number] => 20170312259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA' [patent_app_type] => utility [patent_app_number] => 15/651324 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14421 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12786286 [patent_doc_number] => 20180153931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN [patent_app_type] => utility [patent_app_number] => 15/648930 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17192058 [patent_doc_number] => 11160787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram negative bacterial infections [patent_app_type] => utility [patent_app_number] => 16/316910 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 4238 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12924619 [patent_doc_number] => 09827251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-11-28 [patent_title] => Dosing regimen for sedation with CNS 7056 (remimazolam) [patent_app_type] => utility [patent_app_number] => 15/647143 [patent_app_country] => US [patent_app_date] => 2017-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15290 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647143 [rel_patent_id] =>[rel_patent_doc_number] =>)